Christopher M. Smith - May 27, 2022 Form 4/A - Amendment Insider Report for QuidelOrtho Corp (QDEL)

Role
Director
Signature
/s/ Phillip S. Askim, attorney-in-fact for Christopher M. Smith
Stock symbol
QDEL
Transactions as of
May 27, 2022
Transactions value $
$0
Form type
4/A - Amendment
Date filed
8/1/2022, 07:17 PM
Date Of Original Report
Jun 1, 2022
Previous filing
Jan 5, 2022
Next filing
Jun 8, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction QDEL Common Stock Award +34.6K 34.6K May 27, 2022 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Form 4 originally filed on June 1, 2022 is being amended to correct the vesting schedule with respect to 29,418 restricted stock awards held by the reporting person.
F2 Pursuant to the Business Combination Agreement, dated as of December 22, 2021 (the "Business Combination Agreement") by and among Quidel Corporation, Ortho Clinical Diagnostics Holdings plc ("Ortho"), QuidelOrtho Corporation ("QuidelOrtho"), Orca Holdco, Inc., Laguna Merger Sub, Inc., and Orca Holdco 2, Inc., each ordinary share of Ortho beneficially owned by the Reporting Person at the effective time of the transaction contemplated by the Business Combination Agreement was exchanged for (i) 0.1055 shares of common stock of QuidelOrtho and (ii) $7.14 in cash.
F3 Includes 29,418 restricted stock awards, of which 4,203 shares vested on July 28, 2022, 16,811 shares will vest on September 9, 2022, 4,201 shares will vest on February 28, 2023 and 4,203 shares will vest on May 27, 2023.